美女免费一级视频在线观看
Check out a detailed look inside the collapse of the Food and Drug Administration. The regulatory agency confronts a future determined by a health secretary hostile to its mission. (The New York Times)
Novartis won approval in Switzerland for Coartem Baby, the first drug to treat malaria in babies and young children. Coartem was launched to treat malaria in 1999, and this new dose strength is dissolvable and has a cherry flavor to make it easier to administer. (Reuters)
The Center for Disease Control and Prevention has ended its emergency response to the H5N1 bird flu. The response is the result of declining animal infection and no human cases since February and updates on the virus will become part of routine reports with seasonal influenza. (Axios)
A study published by JAMA Open Network showed immune checkpoint inhibitors improved survival rates in cancer patients, but privately insured patients had a higher survival rate than publicly insured ones. The two-year survival rate of privately insured patients jumped from 29% to 46% whereas publicly insured patients jumped from 16% to 28%. (STAT News)
FDA Commissioner Marty Makary pledged to “meaningfully reduce” unnecessary animal testing that’s currently used to bring new drugs to market. Makary pledged that the agency’s animal testing requirement will be reduced, refined, or potentially replaced using a range of approaches. (Endpoints News)
To read yesterday’s edition of Five things for pharma marketers to know, click here.